Contact Information

Organisation DIA
About Over twenty years of human resources, management consulting and organizational effectiveness experience; began working in patient advocacy in 2014. Currently leading DIA's patient engagement thought leadership strategic initiative, which includes our 'Patients as Partners' program that gives prominent placement of POLs (patient opinion leaders) in DIA's flagship meetings, original research, and publications. Created Patient Advocacy Lifecycle model; contributed significantly to the Considerations Guide, a deliverable of the Patient Engagement Research project in collaboration with Tufts Center for the Study of Drug Development. See more here: Specialties: Patient advocacy programs Organization development Strategic planning Change management Creative meeting & workshop design and facilitation Communications Performance management Training design & delivery Compensation analysis Myers-Briggs Type Indicator Appreciative Inquiry Strengths-based performance First Break All the Rules, Now Discover Your Strengths Crucial Conversations

Patient Pledge

Individual pledge to Patients is a demonstration unifying the whole research community with the same approach of a personal commitment to work with patients for patients. Taking the Pledge to Patients means looking at your everyday activities and asking, “is the patient perspective clearly addressed in everything that I do?” Taking the Pledge to Patients means committing to simple, measurable and sustainable patient-centred principles, that will lead to better and more meaningful patient and healthcare outcomes.

Making a Pledge to Patients involves commitment to 3 guiding principles: listening to patients, co-creating strategies and solutions with patients, and communicating openly and clearly with patients. Are you ready to commit?

I want to commit



  • I commit to reviewing materials and processes with patients who would be impacted.

    Work in progress


  • I commit to continuing to co-creating materials and processes with patients wherever possible.

    Work in progress


  • No commitment yet here



Measuring Return on Engagement

This research was done in collaboration with the Tufts Center for the Study of Drug Development, and comprised of four parts: 1. Capturing...

Asset 5